BriaCell Therapeutics Corp. BCT.TO Stock
BriaCell Therapeutics Corp. Price Chart
BriaCell Therapeutics Corp. BCT.TO Financial and Trading Overview
| BriaCell Therapeutics Corp. stock price | 3.4 CAD |
| Previous Close | 7.65 CAD |
| Open | 7.76 CAD |
| Bid | 7.9 CAD x N/A |
| Ask | 8.01 CAD x N/A |
| Day's Range | 7.75 - 7.96 CAD |
| 52 Week Range | 5.77 - 10.91 CAD |
| Volume | 3.6K CAD |
| Avg. Volume | 8K CAD |
| Market Cap | 126.25M CAD |
| Beta (5Y Monthly) | 1.665847 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.08 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 20 CAD |
BCT.TO Valuation Measures
| Enterprise Value | 95.45M CAD |
| Trailing P/E | N/A |
| Forward P/E | -4.202128 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -4.963 |
Trading Information
BriaCell Therapeutics Corp. Stock Price History
| Beta (5Y Monthly) | 1.665847 |
| 52-Week Change | 6.61% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 10.91 CAD |
| 52 Week Low | 5.77 CAD |
| 50-Day Moving Average | 8.95 CAD |
| 200-Day Moving Average | 8.74 CAD |
BCT.TO Share Statistics
| Avg. Volume (3 month) | 8K CAD |
| Avg. Daily Volume (10-Days) | 2.51K CAD |
| Shares Outstanding | 15.98M |
| Float | 11.2M |
| Short Ratio | 10.56 |
| % Held by Insiders | 23.69% |
| % Held by Institutions | 15.14% |
| Shares Short | 78.16K |
| Short % of Float | 0.55% |
| Short % of Shares Outstanding | 0.48% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:300 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | July 31, 2022 |
| Most Recent Quarter (mrq) | January 31, 2023 |
| Next Fiscal Year End | July 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -29.086% |
| Return on Equity (ttm) | -309.72% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -19231526 CAD |
| Net Income Avi to Common (ttm) | -23454228 CAD |
| Diluted EPS (ttm) | -0.73 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 33.5M CAD |
| Total Cash Per Share (mrq) | 2.16 CAD |
| Total Debt (mrq) | 0 CAD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 50.623 |
| Book Value Per Share (mrq) | -0.083 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -15643690 CAD |
| Levered Free Cash Flow (ttm) | -8932643 CAD |
Profile of BriaCell Therapeutics Corp.
| Country | Canada |
| State | BC |
| City | West Vancouver |
| Address | Bellevue Centre |
| ZIP | V7T 2X1 |
| Phone | N/A |
| Website | https://www.briacell.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
BriaCell Therapeutics Corp., an immuno-oncology-focused biotechnology company, engages in developing immunotherapies for the management of cancer. Its lead drug candidate is Bria-IMT, a whole-cell cancer vaccine that is in Phase I/IIa clinical trials in combination with the immunotherapy development candidates retifanlimab. The company is also developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test that determines the patients' HLA types. It has a non-exclusive clinical trial collaboration with Incyte Corporation to evaluate the effects of combinations of novel clinical candidates; and a cooperative research and development agreement with the National Cancer Institute to conduct preclinical studies to develop and test Bria-OTS cellular immunotherapy as a treatment for cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
Q&A For BriaCell Therapeutics Corp. Stock
What is a current BCT.TO stock price?
BriaCell Therapeutics Corp. BCT.TO stock price today per share is 3.4 CAD.
How to purchase BriaCell Therapeutics Corp. stock?
You can buy BCT.TO shares on the Toronto exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BriaCell Therapeutics Corp.?
The stock symbol or ticker of BriaCell Therapeutics Corp. is BCT.TO.
Which industry does the BriaCell Therapeutics Corp. company belong to?
The BriaCell Therapeutics Corp. industry is Biotechnology.
How many shares does BriaCell Therapeutics Corp. have in circulation?
The max supply of BriaCell Therapeutics Corp. shares is 15.98M.
What is BriaCell Therapeutics Corp. Price to Earnings Ratio (PE Ratio)?
BriaCell Therapeutics Corp. PE Ratio is now.
What was BriaCell Therapeutics Corp. earnings per share over the trailing 12 months (TTM)?
BriaCell Therapeutics Corp. EPS is -1.08 CAD over the trailing 12 months.
Which sector does the BriaCell Therapeutics Corp. company belong to?
The BriaCell Therapeutics Corp. sector is Healthcare.